AllQuantitative Report
logoArgusOctober 15, 2020

RGNX: What does Argus have to say about RGNX?

Symbols
RGNX
Sector(s)
Healthcare
Rating
Current Price
$34.51
Price Target
$NaN
Earnings Estimate
Summary

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free